Filing Details

Accession Number:
0000921895-22-001872
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-02 08:55:21
Reporting Period:
2022-06-01
Accepted Time:
2022-06-02 08:55:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719406 Nrx Pharmaceuticals Inc. NRXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303782 C Jonathan Javitt 1201 North Market Street
Suite 111
Wilmington DE 19801
Chief Scientist Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-01 100,000 $58.00 146,332 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,299,997 Indirect By Trust
Common Stock 1,422,000 Indirect By Trust
Footnotes
  1. Reflects charitable donations of 49,000 shares of Common Stock that occurred in December 2021.
  2. Held by the Jonathan Javitt Living Trust of which the Reporting Person is trustee.
  3. Held by The Javitt 2012 Irrevocable Dynasty Trust of which the Reporting Person is the Grantor.